Sponsor pipeline

Aspeya, Inc. clinical trial pipeline

2 active trials 2 recruiting 2 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Phase 1		1
Phase 2		1

NCT ID	Title	Condition	Status	Updated
Phase 2
NCT07646613	Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine…	Migraine	Recruiting	2026-10-09
Phase 1
NCT07665892	Phase 1 Study Evaluating Safety and Pharmacokinetics of ASY202 in Adults With Asthma	Safety in Asthma Patients	Recruiting	2026-09-02

Get alerts when Aspeya, Inc.'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.